{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:41:02Z","timestamp":1793932862176,"version":"4.8.0"},"reference-count":292,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammatory responses represent a core pathological process driving the progression of both acute and chronic kidney diseases. As a key effector of the innate immune system, the NLRP3 inflammasome is widely activated in renal resident cellsand infiltrating immune cells, positioning it as a critical nexus linking metabolic dysregulation, cellular stress, and tissue injury. Accumulating preclinical and clinical evidence in recent years demonstrates that aberrant activation of the NLRP3 inflammasome directly promotes glomerular damage, tubulointerstitial inflammation, fibrosis, and vascular dysfunction through the release of IL-1\u03b2 and IL-18 and the induction of pyroptosis, thereby contributing to the pathogenesis of diverse renal disorders including acute kidney injury (AKI), diabetic kidney disease (DKD), IgA nephropathy, lupus nephritis, and chronic renal fibrosis. This review systematically delineates the multilayered regulatory mechanisms of the NLRP3 inflammasome within the renal microenvironment\u2014including upstream activating signals, downstream effector pathways, and crosstalk with autophagy, mitochondrial dynamics, and epigenetic regulation. We particularly focus on how disease-specific triggers in kidney pathologies such as hyperglycemia, uric acid, lipotoxicity, and ischemia reperfusion instrumentalize NLRP3 to drive irreversible renal injury. Critically, we provide a comprehensive evaluation of current advances in the development of small-molecule inhibitors targeting the NLRP3 inflammasome pathway, encompassing preclinical and clinical trial data for agents that directly modulate NLRP3 protein conformation, inhibit ASC oligomerization, block caspase-1 activity, or neutralize IL-1\u03b2. We further dissect the differential therapeutic efficacy, tissue selectivity, safety margins, and emerging resistance mechanisms of these inhibitors across distinct renal disease models, while highlighting key translational challenges\u2014including the lack of validated biomarkers, difficulties in patient stratification, and inefficient renal-targeted drug delivery. This review aims to establish a systematic theoretical framework for mechanistic research into renal inflammatory diseases and to provide a target rationale and a clinical development roadmap for the design of next-generation precision anti-inflammatory therapies, thereby accelerating the translation of NLRP3-targeted interventions from bench to bedside for patients with kidney disease.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1703560","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:10:17Z","timestamp":1763615417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Targeting the NLRP3 inflammasome in kidney disease: molecular mechanisms, pathogenic roles, and emerging small-molecule therapeutics"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanfang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12882-023-03391-z","article-title":"Global incidence and death estimates of chronic kidney disease due to hypertension from 1990 to 2019, an ecological analysis of the global burden of diseases 2019 study","volume":"24","author":"Liu","year":"2023","journal-title":"BMC Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00702-3","article-title":"Cell and gene therapy for kidney disease","volume":"19","author":"Peek","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121584","article-title":"The interplay between immune and metabolic pathways in kidney disease","volume":"12","author":"Qu","year":"2023","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042921-101813","article-title":"Genetics of kidney disease: the unexpected role of rare disorders","volume":"74","author":"Elliott","year":"2023","journal-title":"Annu Rev Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41581-022-00586-9","article-title":"Extracellular vesicles in kidney disease","volume":"18","author":"Grange","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115589","article-title":"Kidney inflammation, injury and regeneration 2020","volume":"22","author":"Baer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2023.12.009","article-title":"Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation","volume":"57","author":"Arifuzzaman","year":"2024","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108053","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","volume":"236","author":"Toldo","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101638","article-title":"The NLRP3 inflammasome in fibrosis and aging: The known unknowns","volume":"79","author":"Liu","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2022.101417","article-title":"Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies","volume":"33","author":"Huang","year":"2022","journal-title":"Biochem Biophys Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1196016","article-title":"Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.02.045","article-title":"TLR-induced NF-\u03baB activation regulates NLRP3 expression in murine macrophages","volume":"586","author":"Qiao","year":"2012","journal-title":"FEBS Lett"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00631","article-title":"Small-molecule modulators of toll-like receptors","volume":"53","author":"Wang","year":"2020","journal-title":"Acc Chem Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2020.01.009","article-title":"An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance","volume":"31","author":"He","year":"2020","journal-title":"Cell Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.10.004","article-title":"COPs and POPs patrol inflammasome activation","volume":"430","author":"Indramohan","year":"2018","journal-title":"J Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-019-01174-z","article-title":"Protective effect of a novel (2S, 3R, 4S)-chromene-3-carboxamide derivative, Z20 against sepsis-induced organ injury","volume":"43","author":"Zeng","year":"2020","journal-title":"Inflammation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran","volume":"130","author":"Kim","year":"2007","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104921","article-title":"Curcumin: an inflammasome silencer","volume":"159","author":"Hasanzadeh","year":"2020","journal-title":"Pharmacol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1747","article-title":"MicroRNA-223 inhibits lipopolysaccharide-induced inflammatory response by directly targeting Irak1 in the nucleus pulposus cells of intervertebral disc","volume":"70","author":"Wang","year":"2018","journal-title":"IUBMB Life"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0634-4","article-title":"Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation","volume":"21","author":"Razani","year":"2020","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0073","article-title":"Response and resistance to NF-\u03baB inhibitors in mouse models of lung adenocarcinoma","volume":"1","author":"Xue","year":"2011","journal-title":"Cancer Discov"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010193","article-title":"Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS\/NF-\u03baB\/NLRP3\/GSDMD signal axis in non-small cell lung cancer","volume":"12","author":"Teng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/imm.13221","article-title":"Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture","volume":"161","author":"Hoyle","year":"2020","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.422238","article-title":"Deubiquitinases regulate the activity of caspase-1 and interleukin-1\u03b2 secretion via assembly of the inflammasome","volume":"288","author":"Lopez-Castejon","year":"2013","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-021-00741-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000373","article-title":"Function and regulation of noncanonical caspase-4\/5\/11 inflammasome","volume":"204","author":"Matikainen","year":"2020","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cgh.2018.06.012","article-title":"Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo","volume":"17","author":"Frenette","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K+ Efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0444-5","article-title":"Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","article-title":"Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages","volume":"49","author":"Guo","year":"2018","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0326-x","article-title":"MicroRNA-33\/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.cmet.2019.03.011","article-title":"Choline uptake and metabolism modulate macrophage IL-1\u03b2 and IL-18 production","volume":"29","author":"Sanchez-Lopez","year":"2019","journal-title":"Cell Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.dld.2020.05.032","article-title":"Motivation to pursue anti-TNF\u03b1 treatment in patients with Crohn's disease - the SPACE motivation study","volume":"52","author":"D'Amico","year":"2020","journal-title":"Dig Liver Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00229","article-title":"The role of IL-10 in malaria: A double edged sword","volume":"10","author":"Kumar","year":"2019","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202005_21356","article-title":"Carbachol alleviates myocardial injury in septic rats through PI3K\/AKT signaling pathway","volume":"24","author":"Zhou","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2020.04.005","article-title":"Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation","volume":"143","author":"Cao","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818625","article-title":"Role of ROS-induced NLRP3 inflammasome activation in the formation of calcium oxalate nephrolithiasis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154748","article-title":"Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy","volume":"118","author":"Wu","year":"2021","journal-title":"Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"496","DOI":"10.7501\/j.issn.1674-6376.2024.03.006","article-title":"Mechanism of resveratrol in protecting kidneys of rats with gouty nephropathy via the NF-\u03baB\/NLRP3\/caspase-1 signaling axis","volume":"47","author":"Xu","year":"2024","journal-title":"Drug Eval Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7154","article-title":"Beneficial effect of magnolol on lupus nephritis in MRL\/lpr mice by attenuating the NLRP3 inflammasome and NF\u2212\u03baB signaling pathway: A mechanistic analysis","volume":"16","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2018.07.009","article-title":"Icariin alleviates murine lupus nephritis via inhibiting NF-\u03baB activation pathway and NLRP3 inflammasome","volume":"208","author":"Su","year":"2018","journal-title":"Life Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/art.38174","article-title":"P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3\/ASC\/caspase 1 pathway","volume":"65","author":"Zhao","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903287R","article-title":"P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling","volume":"34","author":"Han","year":"2020","journal-title":"FASEB J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6973175","article-title":"High glucose and LPS prime NLRP3 inflammasome via ROS\/TXNIP pathway in mesangial cells","volume":"2016","author":"Feng","year":"2016","journal-title":"J Diabetes Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0108-8","article-title":"Pterostilbene attenuates early brain injury following subarachnoid hemorrhage via inhibition of the NLRP3 inflammasome and nox2-related oxidative stress","volume":"54","author":"Liu","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/504761","article-title":"NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia","volume":"2015","author":"Gao","year":"2015","journal-title":"J Diabetes Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbi.2017.10.012","article-title":"Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway","volume":"278","author":"Wang","year":"2017","journal-title":"Chem Biol Interact"},{"key":"B58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biocel.2018.02.015","article-title":"mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI","volume":"98","author":"Wen","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201959","article-title":"Inflammasome-independent NLRP3 augments TGF-\u03b2 signaling in kidney epithelium","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.09.022","article-title":"The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury","volume":"93","author":"Anders","year":"2018","journal-title":"Kidney Int"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.14","article-title":"NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis","volume":"23","author":"Chung","year":"2016","journal-title":"Cell Death Differ"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300842","article-title":"A novel mitochondrial MAVS\/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax\/Bak-independent apoptosis","volume":"192","author":"El Maadidi","year":"2014","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02563","article-title":"Inflammasome-independent role of NLRP3 mediates mitochondrial regulation in renal injury","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2024.07.013","article-title":"Higher dietary inflammatory index and systemic immune-inflammation index score are associated with higher risk of chronic kidney disease: analysis of the national health and nutrition examination survey from 1999 to 2018","volume":"35","author":"Guo","year":"2025","journal-title":"J Ren Nutr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/rco2.75","article-title":"A toll-like receptor-4\/NLRP3 inflammasome pathway promotes inflammation in skeletal muscle of chronic kidney disease patients","volume":"6","author":"Verzola","year":"2023","journal-title":"JCSM Rapid Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad135","article-title":"Leukocyte-endothelial interaction in CKD","volume":"16","author":"Sarakpi","year":"2023","journal-title":"Clin Kidney J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.40155","article-title":"Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2014.01.033","article-title":"Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing","volume":"1843","author":"Boini","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B70","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.1038\/s41598-017-11089-0","article-title":"Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice","volume":"7","author":"Ikeda","year":"2017","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00203.2014","article-title":"Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury","volume":"308","author":"Zhuang","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1038\/emm.2017.287","article-title":"Impaired Na+-K+-ATPase signaling in renal proximal tubule contributes to hyperuricemia-induced renal tubular injury","volume":"50","author":"Xiao","year":"2018","journal-title":"Exp Mol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.12659\/msm.903269","article-title":"Function of NLRP3 in the pathogenesis and development of diabetic nephropathy","volume":"23","author":"Fu","year":"2017","journal-title":"Med Sci Monit"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1001-7097.2015.10.007","article-title":"Effect of albumin on the expression of NLRP3 inflammasome in renal tubular epithelial cells","volume":"31","author":"Lihong","year":"2015","journal-title":"Chin J Nephrol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0122272","DOI":"10.1371\/journal.pone.0122272","article-title":"NLRP3 inflammasome activation in dialyzed chronic kidney disease patients","volume":"10","author":"Granata","year":"2015","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.161","article-title":"The NLRP3\/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms","volume":"86","author":"Andersen","year":"2014","journal-title":"Kidney Int"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20231123.401","article-title":"Mechanism of traditional Chinese medicine in regulating NLRP3 inflammasomes to alleviate renal interstitial fibrosis in diabetic nephropathy: a review","volume":"49","author":"Qiao","year":"2024","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.09.001","article-title":"Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome\/IL-1\u03b2\/Smad circuit","volume":"97","author":"Zhang","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1038\/s41598-017-08689-1","article-title":"NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a Syk-dependent manner","volume":"7","author":"Lu","year":"2017","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4666","article-title":"NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia","volume":"18","author":"Abais","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015060676","article-title":"Caspase-1, but not caspase-3, promotes diabetic nephropathy","volume":"27","author":"Shahzad","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.064840","article-title":"Global characterization of protein secretion from human macrophages following non-canonical caspase-4\/5 inflammasome activation","volume":"16","author":"Lorey","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000917","article-title":"Podocyte metabolic reprogramming and targeted therapy","volume":"13","author":"Hu","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13046","article-title":"Differential role of the NLRP3 inflammasome in infection and tumorigenesis","volume":"156","author":"Tartey","year":"2019","journal-title":"Immunology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00155","article-title":"Inhibition of NLRP3 inflammasome: A prospective target for the treatment of ischemic stroke","volume":"14","author":"Feng","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","article-title":"CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204900","article-title":"Gadolinium-based compounds induce NLRP3-dependent IL-1\u03b2 production and peritoneal inflammation","volume":"74","author":"Schmidt-Lauber","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B92","article-title":"Interleukin-1beta-induced transdifferentiation of renal proximal tubular cells is mediated by p38 mitogen-activated protein kinase phosphorylation","volume":"83","author":"Zhang","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00534.2015","article-title":"NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5\/6 nephrectomy","volume":"310","author":"Gong","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8316560","article-title":"NLRP3 deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease","volume":"2017","author":"Guo","year":"2017","journal-title":"Mediators Inflammation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"111488","DOI":"10.1016\/j.yexcr.2019.07.001","article-title":"NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation","volume":"383","author":"Li","year":"2019","journal-title":"Exp Cell Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13970","article-title":"Progress in genetics of type 2 diabetes and diabetic complications","volume":"14","author":"Shojima","year":"2023","journal-title":"J Diabetes Investig"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108314","article-title":"A natural products solution to diabetic nephropathy therapy","volume":"241","author":"Hu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12845","article-title":"Expression of inflammasome complex mRNA and its targeted microRNA in type 2 diabetes mellitus: A possible predictor of the severity of diabetic nephropathy","volume":"11","author":"Bhattacharjee","year":"2019","journal-title":"J Diabetes"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1645","article-title":"NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients","volume":"69","author":"El-Horany","year":"2017","journal-title":"IUBMB Life"},{"key":"B100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Wada","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-019-09501-8","article-title":"Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy","volume":"36","author":"Du","year":"2020","journal-title":"Cell Biol Toxicol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051516","article-title":"Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP\/NLRP3 pathway","volume":"12","author":"An","year":"2020","journal-title":"Nutrients"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1390418","article-title":"Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation","volume":"2018","author":"Wang","year":"2018","journal-title":"J Diabetes Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nature07383","article-title":"Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production","volume":"456","author":"Saitoh","year":"2008","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2017.10.088","article-title":"Mitophagy regulates macrophage phenotype in diabetic nephropathy rats","volume":"494","author":"Zhao","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.10.194","article-title":"NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy","volume":"521","author":"Hou","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00503.2023","article-title":"Pyroptosis in health and disease","volume":"326","author":"Imre","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.02.001","article-title":"Role of pyroptosis in the pathogenesis of various neurological diseases","volume":"117","author":"Oladapo","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12964-023-01458-w","article-title":"Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases","volume":"22","author":"Liang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S291453","article-title":"Role of pyroptosis in diabetes and its therapeutic implications","volume":"14","author":"Mamun","year":"2021","journal-title":"J Inflammation Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010426","article-title":"Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity","volume":"22","author":"Tsuchiya","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.030130","article-title":"Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis","volume":"10","author":"Olson","year":"2017","journal-title":"Dis Model Mech"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607769113","article-title":"GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes","volume":"113","author":"Aglietti","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12787","article-title":"Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses","volume":"152","author":"Yi","year":"2017","journal-title":"Immunology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2205-2","article-title":"The intersection of cell death and inflammasome activation","volume":"73","author":"Vince","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900383","article-title":"Teleost gasdermin E is cleaved by caspase 1, 3, and 7 and induces pyroptosis","volume":"203","author":"Jiang","year":"2019","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00471.2016","article-title":"Inflammation drives renal scarring in experimental pyelonephritis","volume":"312","author":"Li","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e928411","DOI":"10.12659\/MSM.928411","article-title":"Gasdermin D protects mouse podocytes against high-glucose-induced inflammation and apoptosis via the C-jun N-terminal kinase (JNK) pathway","volume":"27","author":"Li","year":"2021","journal-title":"Med Sci Monit"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e72344","DOI":"10.1371\/journal.pone.0072344","article-title":"Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells","volume":"8","author":"Fang","year":"2013","journal-title":"PloS One"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6973175","article-title":"High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS\/TXNIP pathway in mesangial cells","volume":"2016","author":"Feng","year":"2016","journal-title":"J Diabetes Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6207563","article-title":"RIPK2-mediated autophagy and negatively regulated ROS-NLRP3 inflammasome signaling in GMCs stimulated with high glucose","volume":"2019","author":"Gao","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3892\/mmr.2018.9164","article-title":"Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome\u2212mediated IL\u22121\u03b2 secretion via c\u2212Jun N\u2212terminal kinase activation and cell apoptosis during diabetic nephropathy","volume":"18","author":"Qiao","year":"2018","journal-title":"Mol Med Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.11.004","article-title":"Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy","volume":"114","author":"Qiu","year":"2016","journal-title":"Pharmacol Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.307312","article-title":"p38\u03b4 MAPK: A novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis","volume":"36","author":"Rajam\u00e4ki","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184531","article-title":"Blockade of the adenosine A3 receptor attenuates caspase 1 activation in renal tubule epithelial cells and decreases interleukins IL-1\u03b2 and IL-18 in diabetic rats","volume":"20","author":"Garrido","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201801749RRR","article-title":"Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.12.021","article-title":"Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4\/NF-\u03baB signaling","volume":"57","author":"Han","year":"2019","journal-title":"Phytomedicine"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1039\/c8fo01653d","article-title":"Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation","volume":"10","author":"Ge","year":"2019","journal-title":"Food Funct"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e2583","DOI":"10.1038\/cddis.2016.451","article-title":"LincRNA-Gm4419 knockdown ameliorates NF-\u03baB\/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy","volume":"8","author":"Yi","year":"2017","journal-title":"Cell Death Dis"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00567","article-title":"Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1\/2-Mediated NLRP3 Inflammasome Activation","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.045","article-title":"Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-\u03baB and NLRP3 inflammasome pathways","volume":"106","author":"Zhu","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3115-6","article-title":"Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-\u03baB\/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis","volume":"57","author":"Yang","year":"2014","journal-title":"Diabetologia"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.036","article-title":"Apocynin inhibited NLRP3\/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy","volume":"106","author":"Xin","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/srep34228","article-title":"Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy","volume":"6","author":"Shahzad","year":"2016","journal-title":"Sci Rep"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.073","article-title":"Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway","volume":"225","author":"Yu","year":"2019","journal-title":"Life Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27950","article-title":"Protective effects of plant-derived natural products on renal complications","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4163","article-title":"Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD\u2212like receptor protein 3 inflammatory corpuscle","volume":"43","author":"Gu","year":"2019","journal-title":"Int J Mol Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1896041","article-title":"Verapamil attenuated prediabetic neuropathy in high-fat diet-fed mice through inhibiting TXNIP-mediated apoptosis and inflammation","volume":"2019","author":"Xu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2018.08.002","article-title":"NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice","volume":"478","author":"Wu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1530\/JME-18-0069","article-title":"Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells","volume":"61","author":"Song","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S199802","article-title":"A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation","volume":"12","author":"Zhang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02277","article-title":"Interleukin-22 attenuated renal tubular injury in aristolochic acid nephropathy via suppressing activation of NLRP3 inflammasome","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.08.134","article-title":"Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3\/ASC\/Caspase-1 signaling pathway","volume":"107","author":"Liu","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B146","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1038\/s41598-017-07182-z","article-title":"Implication of REDD1 in the activation of inflammatory pathways","volume":"7","author":"Pastor","year":"2017","journal-title":"Sci Rep"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01091","article-title":"Inhibiting the inflammasome: A chemical perspective","volume":"59","author":"Baldwin","year":"2016","journal-title":"J Med Chem"},{"key":"B148","article-title":"Losartan inhibits LPS + ATP-induced IL-1beta secretion from mouse primary macrophages by suppressing NALP3 inflammasome","volume":"69","author":"Wang","year":"2014","journal-title":"Pharmazie"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.07.027","article-title":"Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-\u03baB\/p38 signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"63","author":"Song","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/antib12020040","article-title":"IgA nephropathy: current treatment and new insights","volume":"12","author":"Petrou","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad146","article-title":"IgA nephropathy in adults-treatment standard","volume":"38","author":"Gleeson","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B153","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010082","article-title":"The role of NLRP3 inflammasome in igA nephropathy","volume":"59","author":"Wu","year":"2022","journal-title":"Med (Kaunas)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2021.1989461","article-title":"LncRNA CRNDE exacerbates igA nephropathy progression by promoting NLRP3 inflammasome activation in macrophages","volume":"51","author":"Shen","year":"2022","journal-title":"Immunol Invest"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/srep41123","article-title":"NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy","volume":"7","author":"Tsai","year":"2017","journal-title":"Sci Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900284","article-title":"IgA nephropathy benefits from compound K treatment by inhibiting NF-\u03baB\/NLRP3 inflammasome and enhancing autophagy and SIRT1","volume":"205","author":"Wu","year":"2020","journal-title":"J Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01080","article-title":"Zhen-wu-tang protects igA nephropathy in rats by regulating exosomes to inhibit NF-\u03baB\/NLRP3 pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15663","article-title":"Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction","volume":"24","author":"Wu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-8982.2022.02.007","article-title":"Correlation between peripheral blood microRNA-223 and NLRP3 levels and renal interstitial fibrosis in patients with IgA nephropathy","volume":"32","author":"Fuying","year":"2022","journal-title":"Chin J Modern Med"},{"key":"B161","doi-asserted-by":"publisher","first-page":"415","DOI":"10.16424\/j.cnki.cn32-1807\/r.2022.05.004","article-title":"Expression of NLRP3 in serum exosomes of patients with IgA nephropathy and its correlation with disease severity","volume":"42","author":"Cao","year":"2022","journal-title":"J Nantong Univ (Medical Sciences)"},{"key":"B162","volume-title":"Expression of NLRP3 and IL-18 in renal tissues of patients with IgA nephropathy and their relationship with clinicopathological parameters and MCP-1","author":"Hu","year":"2014"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies","volume":"79","author":"El Karoui","year":"2011","journal-title":"Kidney Int"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.466","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies","volume":"79","author":"Hill","year":"2011","journal-title":"Kidney Int"},{"key":"B165","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/0003484","article-title":"Role of podocyte injury in IgA nephropathy","volume":"181","author":"Menon","year":"2013","journal-title":"Contrib Nephrol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.740527","article-title":"The glomerulus according to the mesangium","volume":"8","author":"Ebefors","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.10.012","article-title":"TRIM40 inhibits IgA1-induced proliferation of glomerular mesangial cells by inactivating NLRP3 inflammasome through ubiquitination","volume":"140","author":"Shen","year":"2021","journal-title":"Mol Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-484X.2020.24.004","article-title":"miR-223 alleviates renal injury in rats with immunoglobulin A nephropathy by regulating the NLRP3 inflammasome","volume":"36","author":"Wang","year":"2020","journal-title":"Chin J Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.10.013","article-title":"Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy","volume":"49","author":"Kusano","year":"2016","journal-title":"Hum Pathol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000508079","article-title":"Elevated endostatin expression is regulated by the pIgA immune complex and associated with disease severity of IgA nephropathy","volume":"46","author":"Zhai","year":"2021","journal-title":"Kidney Blood Press Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac204","article-title":"Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries","volume":"37","author":"Makita","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1957748","article-title":"Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase \u03b1 (AMPK\u03b1) in renal glomerular endothelial cells","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.036","article-title":"Retinoic acid receptor responder1 promotes development of glomerular diseases via the Nuclear Factor-\u03baB signaling pathway","volume":"100","author":"M\u00f6ller-Hackbarth","year":"2021","journal-title":"Kidney Int"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2018.05.018","article-title":"Role of mesangial-podocytic-tubular cross-talk in IgA nephropathy","volume":"38","author":"Leung","year":"2018","journal-title":"Semin Nephrol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1159\/000514183","article-title":"Role of human mesangial-tubular crosstalk in secretory IgA-induced IgA nephropathy","volume":"46","author":"Zhang","year":"2021","journal-title":"Kidney Blood Press Res"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/srep24667","article-title":"NLRP3 localizes to the tubular epithelium in human kidney and correlates with outcome in IgA nephropathy","volume":"6","author":"Chun","year":"2016","journal-title":"Sci Rep"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41598-023-48248-5","article-title":"Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics","volume":"14","author":"Zeng","year":"2024","journal-title":"Sci Rep"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/life13071514","article-title":"Triterpenes as potential drug candidates for rheumatoid arthritis treatment","volume":"13","author":"Faustino","year":"2023","journal-title":"Life (Basel)"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.13193\/j.issn.1673-7717.2021.05.044","article-title":"Research progress on the signal transduction mechanisms related to the anti-inflammatory effects of tripterygium wilfordii","volume":"39","author":"Chen","year":"2021","journal-title":"Chin Arch Traditional Chin Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.12360\/CPB202111086","article-title":"Tripterygium wilfordii diterpenoids alleviate macrophage inflammatory response by inhibiting multiple signaling pathways","volume":"39","author":"Rao","year":"2023","journal-title":"Chin Pharmacol Bull"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-7386.2017.12.038","article-title":"Research progress on the pharmacological effects and molecular mechanisms of triptolide","volume":"39","author":"Jin","year":"2017","journal-title":"Hebei Med J"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.13898\/j.cnki.issn.1000-2200.2020.12.001","article-title":"Renoprotective effect of triptolide in rats with IgA nephropathy and its impact on the NLRP3 inflammasome","volume":"45","author":"Zhou","year":"2020","journal-title":"J Bengbu Med Coll"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1080265","article-title":"Anti-inflammatory effects of triptolide on IgA nephropathy in rats","volume":"37","author":"He","year":"2015","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.7501\/j.issn.0253-2670.2021.14.030","article-title":"Research progress on the antitumor mechanisms of celastrol used alone or in combination","volume":"52","author":"Xu","year":"2021","journal-title":"Chin Traditional Herbal Drugs"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.08.036","article-title":"A new mechanism of inhibition of IL-1\u03b2 secretion by celastrol through the NLRP3 inflammasome pathway","volume":"814","author":"Xin","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-8348.2016.25.001","article-title":"Effects of celastrol on the expression of the notch signaling pathway in renal tissues of rats with IgA nephropathy","volume":"45","author":"Liu","year":"2016","journal-title":"Chongqing Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-7562.2022.08.003","article-title":"Effects of wogonoside on the NF-\u03baB\/NLRP3 pathway and mesangial proliferation in rats with igA nephropathy","volume":"50","author":"Fan","year":"2022","journal-title":"Modern Med J"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-9202.2021.23.031","article-title":"Effects of baicalin on cell apoptosis and the NLRP3\/caspase-1 pathway in rats with mesangial proliferative glomerulonephritis","volume":"41","author":"Zhang","year":"2021","journal-title":"Chin J Gerontology"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.13418\/j.issn.1001-165x.2020.03.013","article-title":"Experimental study on the mechanism of plumbagin in alleviating igA nephropathy injury by regulating ROS and inhibiting the NLRP3 inflammasome","volume":"38","author":"Liu","year":"2020","journal-title":"Chin J Clin Anat"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.13431\/j.cnki.immunol.j.20190161","article-title":"The protective effect and mechanism of plumbagin in alleviating renal injury in rats with immunoglobulin A nephropathy","volume":"35","author":"Liang","year":"2019","journal-title":"J Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-6469.2016.08.007","article-title":"Plumbagin inhibits proliferation of glomerular mesangial cells and expression of fibrosis-related factors","volume":"20","author":"Xie","year":"2016","journal-title":"Anhui Med Pharm J"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.13431\/j.cnki.immunol.j.20200135","article-title":"Geniposide alleviates inflammatory response and oxidative stress in igA nephropathy model mice by modulating NLRP3","volume":"36","author":"Pang","year":"2020","journal-title":"J Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-7856.2017.01.015","article-title":"Effects and related mechanisms of icariin on experimental igA nephropathy in rats","volume":"27","author":"Zhang","year":"2017","journal-title":"Chin J Comp Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.13431\/j.cnki.immunol.j.20180060","article-title":"Regulatory effects of icariin on fibrosis and inflammatory response in rats with igA nephropathy","volume":"34","author":"Zhao","year":"2018","journal-title":"J Immunol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/2211-5463.12161","article-title":"Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b\/Nlrp3 pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"FEBS Open Bio"},{"key":"B196","volume-title":"Study on the therapeutic effects and mechanisms of artemisinin in mice with IgA nephropathy","author":"Yang","year":"2022"},{"key":"B197","volume-title":"Study on the role of artemisinin combined with hydroxychloroquine-mediated exosomes in IgA nephropathy","author":"Bai","year":"2019"},{"key":"B198","doi-asserted-by":"publisher","first-page":"e77794","DOI":"10.1371\/journal.pone.0077794","article-title":"Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-\u03baB\/NLRP3 pathway","volume":"8","author":"Hua","year":"2013","journal-title":"PloS One"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00732-x","article-title":"Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants","volume":"19","author":"Vinuesa","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu Rev Med"},{"key":"B201","doi-asserted-by":"publisher","first-page":"e001114","DOI":"10.1136\/lupus-2023-001114","article-title":"Clinical trial outcomes for SLE: what we have and what we need","volume":"11","author":"Arnaud","year":"2024","journal-title":"Lupus Sci Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J Immunol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/art.38993","article-title":"Lupus nephritis: glycogen synthase kinase 3\u03b2 promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice","volume":"67","author":"Zhao","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600659","article-title":"Hyperactivation of the NLRP3 inflammasome in myeloid cells leads to severe organ damage in experimental lupus","volume":"198","author":"Lu","year":"2017","journal-title":"J Immunol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3760\/j:issn:0254-5101.2006.04.006","article-title":"Therapeutic effects of a selective caspase-1 inhibitor in BXSB lupus nephritis mice","author":"Liu","year":"2006","journal-title":"Chin J Microbiol Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1002\/art.38225","article-title":"An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage","volume":"66","author":"Kahlenberg","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B208","article-title":"IL-1 beta-deficient mice are resistant to induction of experimental SLE","volume":"17","author":"Voronov","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.141.9.3050","article-title":"Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis","volume":"141","author":"Boswell","year":"1988","journal-title":"J Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.04.009","article-title":"Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18","volume":"4","author":"Calvani","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-587X.2006.02.003","article-title":"Plasma levels of interleukin-18 and its expression in renal tissue in lupus nephritis mice","volume":"7","author":"Lu","year":"2006","journal-title":"Chin J Integrated Traditional Western Nephrol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-8982.2010.18.020","article-title":"Study on the expression and secretion of IL-18BP in renal tissue and peripheral blood of patients with lupus nephritis","volume":"20","author":"Yao","year":"2010","journal-title":"Chin J Modern Med"},{"key":"B213","article-title":"Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis","volume":"3","author":"Liang","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5096741","article-title":"IL-1\u03b2 and IL-6 are highly expressed in RF+IgE+ Systemic lupus erythematous subtype","volume":"2017","author":"Wu","year":"2017","journal-title":"J Immunol Res"},{"key":"B215","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15171\/jnp.2016.05","article-title":"Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus","volume":"5","author":"Jafari-Nakhjavani","year":"2016","journal-title":"J Nephropathol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402859","article-title":"Deficient NLRP3 and AIM2 inflammasome function in autoimmune NZB mice","volume":"195","author":"Sester","year":"2015","journal-title":"J Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205496","article-title":"NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-\u03b2 receptor signalling","volume":"74","author":"Lech","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B218","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2567.2011.03462.x","article-title":"Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation","volume":"134","author":"Narayan","year":"2011","journal-title":"Immunology"},{"key":"B219","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J Transl Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.189688","article-title":"Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia","volume":"60","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.02.027","article-title":"Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia","volume":"106","author":"Conley","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.116.233239","article-title":"Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes","volume":"358","author":"Li","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6593","article-title":"RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys","volume":"234","author":"Chen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.662064","article-title":"Megalin\/cubulin-lysosome-mediated albumin reabsorption is involved in the tubular cell activation of NLRP3 inflammasome and tubulointerstitial inflammation","volume":"290","author":"Liu","year":"2015","journal-title":"J Biol Chem"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8243","article-title":"Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury","volume":"7","author":"Ding","year":"2016","journal-title":"Oncotarget"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/137072","article-title":"Mediators of inflammation in acute kidney injury","volume":"2009","author":"Akcay","year":"2009","journal-title":"Mediators Inflammation"},{"key":"B228","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1440-1797.2006.00737.x","article-title":"Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells","volume":"12","author":"Liang","year":"2007","journal-title":"Nephrol (Carlton)"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1002\/art.10563","article-title":"Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis","volume":"46","author":"Faust","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B230","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/CS20160421","article-title":"Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation","volume":"131","author":"Yung","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft332","article-title":"Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis","volume":"29","author":"Lorenz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1159\/000480340","article-title":"Involvement of S100A8\/A9-TLR4-NLRP3 inflammasome pathway in contrast-induced acute kidney injury","volume":"43","author":"Tan","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1038\/srep10901","article-title":"Role of NLRP3 inflammasomes for rhabdomyolysis-induced acute kidney injury","volume":"5","author":"Komada","year":"2015","journal-title":"Sci Rep"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13379","article-title":"Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury","volume":"282","author":"Cao","year":"2015","journal-title":"FEBS J"},{"key":"B236","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/nep.13781","article-title":"Nodakenin alleviates renal ischaemia-reperfusion injury via inhibiting reactive oxygen species-induced NLRP3 inflammasome activation","volume":"26","author":"Liao","year":"2021","journal-title":"Nephrol (Carlton)"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908698106","article-title":"Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome","volume":"106","author":"Iyer","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.205732","article-title":"NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury","volume":"346","author":"Kim","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101718","article-title":"NLRP3 inflammasome: A potential therapeutic target to minimize renal ischemia\/reperfusion injury during transplantation","volume":"75","author":"Su","year":"2022","journal-title":"Transpl Immunol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/1871527315666160321111829","article-title":"NLRP3 is involved in ischemia\/reperfusion injury","volume":"15","author":"Guo","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: A state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1918-6","article-title":"Initiation of the inflammatory response after renal ischemia\/reperfusion injury during renal transplantation","volume":"50","author":"Gu","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1303110","article-title":"Inflammasome pathway in kidney transplantation","volume":"10","author":"Granata","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B244","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MNH.0000000000000190","article-title":"Ischemia as a factor affecting innate immune responses in kidney transplantation","volume":"25","author":"Kasimsetty","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2023.9838","article-title":"Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy","volume":"24","author":"Zhang","year":"2023","journal-title":"Biomol BioMed"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.7150\/thno.70830","article-title":"Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1\/NLRP3\/Caspase-1 pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5992436","article-title":"Naringenin alleviates renal ischemia reperfusion injury by suppressing ER stress-induced pyroptosis and apoptosis through activating nrf2\/HO-1 signaling pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111389","article-title":"The role of inflammasome-dependent and inflammasome-independent NLRP3 in the kidney","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.12.018","article-title":"The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity","volume":"21","author":"Schneider","year":"2017","journal-title":"Cell Rep"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Schmid-Burgk","year":"2015","journal-title":"Eur J Immunol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002330","article-title":"An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury","volume":"185","author":"Shigeoka","year":"2010","journal-title":"J Immunol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12882-019-1506-8","article-title":"Uric acid regulates NLRP3\/IL-1\u03b2 signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K+ efflux","volume":"20","author":"Yin","year":"2019","journal-title":"BMC Nephrol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn11213720190803-01731","article-title":"Implications of EET in renal ischemia\/reperfusion by regulating NLRP3 expression and pyroptosis","volume":"100","author":"Zhu","year":"2020","journal-title":"Natl Med J China"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-782102","article-title":"Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition","volume":"130","author":"Nazir","year":"2017","journal-title":"Blood"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117791","article-title":"Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis","volume":"254","author":"Huang","year":"2020","journal-title":"Life Sci"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160462","article-title":"Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome","volume":"214","author":"Neudecker","year":"2017","journal-title":"J Exp Med"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1159\/000470822","article-title":"MicroRNA-9 inhibits NLRP3 inflammasome activation in human atherosclerosis inflammation cell models through the JAK1\/STAT signaling pathway","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.celrep.2020.01.030","article-title":"Targeting macrophage histone H3 modification as a leishmania strategy to dampen the NF-\u03baB\/NLRP3-mediated inflammatory response","volume":"30","author":"Lecoeur","year":"2020","journal-title":"Cell Rep"},{"key":"B260","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12906-018-2257-y","article-title":"Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.03.035","article-title":"An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice","volume":"90","author":"Ludwig-Portugall","year":"2016","journal-title":"Kidney Int"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{ [1-(4-amino-3-chloro-phenyl)-methanoyl] -amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B265","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbadis.2013.10.012","article-title":"Prophylactic systemic P2X7 receptor blockade prevents experimental colitis","volume":"1842","author":"Marques","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0902531106","article-title":"Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury","volume":"106","author":"Peng","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.153","article-title":"P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats","volume":"35","author":"Ji","year":"2012","journal-title":"Hypertens Res"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8776","article-title":"Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease","volume":"17","author":"Yin","year":"2018","journal-title":"Mol Med Rep"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000189","article-title":"Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells","volume":"69","author":"Qi","year":"2006","journal-title":"Kidney Int"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq355","article-title":"Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy","volume":"26","author":"Tan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B272","article-title":"Tranilast attenuates TGF-\u03b21-induced epithelial-mesenchymal transition in the NRK-52E cells","volume":"27","author":"Li","year":"2014","journal-title":"Pak J Pharm Sci"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000139066.77892.04","article-title":"Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model","volume":"15","author":"Kelly","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-7347.2013.12.006","article-title":"Role and mechanism of tranilast preventing the progression of tubulointerstilial f ibrosis in diabetic kidney diseases","volume":"38","author":"Luo","year":"2013","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04571-8","article-title":"Sleeve gastroplasty combined with the NLRP3 inflammasome inhibitor CY-09 reduces body weight, improves insulin resistance and alleviates hepatic steatosis in mouse model","volume":"30","author":"Sun","year":"2020","journal-title":"Obes Surg"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.2174\/1874467213666200810140749","article-title":"Molecular mechanism of a specific NLRP3 inhibitor to alleviate seizure severity induced by pentylenetetrazole","volume":"14","author":"Shen","year":"2021","journal-title":"Curr Mol Pharmacol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J Rheumatol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12882-020-01861-2","article-title":"Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats","volume":"21","author":"Pereira","year":"2020","journal-title":"BMC Nephrol"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.11.007","article-title":"Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease","volume":"79","author":"Diwan","year":"2014","journal-title":"Pharmacol Res"},{"key":"B280","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JIR.S51250","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J Inflammation Res"},{"key":"B281","doi-asserted-by":"publisher","first-page":"3172647","DOI":"10.1155\/2019\/8247280","article-title":"CD36-mediated lipid accumulation and activation of NLRP3 inflammasome lead to podocyte injury in obesity-related glomerulopathy","volume":"2019","author":"Zhao","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B282","doi-asserted-by":"publisher","first-page":"e0234039","DOI":"10.1371\/journal.pone.0234039","article-title":"NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture","volume":"15","author":"Cornelius","year":"2020","journal-title":"PloS One"},{"key":"B283","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B284","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"key":"B285","doi-asserted-by":"publisher","first-page":"e015513","DOI":"10.1161\/JAHA.119.015513","article-title":"Novel role for tranilast in regulating NLRP3 ubiquitination, vascular inflammation, and atherosclerosis","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2015-0070","article-title":"Tranilast ameliorates cyclophosphamide-induced lung injury and nephrotoxicity","volume":"94","author":"Said","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.01.160","article-title":"Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor \u03b2\/Smad pathways","volume":"43","author":"Tao","year":"2011","journal-title":"Transplant Proc"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14998","article-title":"Cathelicidin-related antimicrobial peptide protects against ischaemia reperfusion-induced acute kidney injury in mice","volume":"177","author":"Pan","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"113619","DOI":"10.1016\/j.bcp.2019.08.021","article-title":"Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-\u03baB signaling and NLRP3 inflammasome activation by exosomes in rats","volume":"169","author":"Bai","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.6.1109","article-title":"Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney","volume":"12","author":"Tesch","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"B292","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1703560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:10:39Z","timestamp":1763615439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1703560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":292,"alternative-id":["10.3389\/fimmu.2025.1703560"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1703560","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1703560"}}